OHSU research drives FDA approval for novel use of anemia drug in brain cancer imaging-2
Credit: OHSU News
Researchers with OHSU’s Neuro-Oncology Blood-Brain Barrier Program supported several clinical trials investigating a novel use of a drug for brain cancer imaging; the data helped achieve its recent FDA-approval. (OHSU/Christine Torres Hicks)